Glaxo Gets Positive EMA Opinion For Label Expansion Of Trelegy Ellipta
LONDON (Alliance News) - GlaxoSmithKline PLC on Friday said it has received a positive opinion on broadening the use of its Trelegy Ellipta inhaler in patients with chronic obstructive pulmonary a Read More